Sofwave MedicalSOFWF 48 EV-to-FCF is 34.76 as of Jun. 30, 2026. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $11.23 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Sofwave Medical ranks worse than 66.27% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sofwave Medical's Enterprise Value is $458.40 Mil.
Sofwave Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $13.19 Mil. Therefore, Sofwave Medical's EV-to-FCF for today is 34.76.
The historical rank and industry rank for Sofwave Medical's EV-to-FCF or its related term are showing as below:
SOFWF'
s EV-to-FCF Range Over the Past 10 Years
Min: -87.55 Med: -17.02 Max: 144.94
Current: 35
During the past 8 years, the highest EV-to-FCF of Sofwave Medical was 144.94. The lowest was -87.55. And the median was -17.02.
SOFWF's EV-to-FCF is ranked worse than 66.27% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.765
vs SOFWF: 35.00
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sofwave Medical (OTCPK:SOFWF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sofwave Medical's PE Ratio (TTM) for today is calculated as:
Sofwave Medical's share price for today is $16.00.
Sofwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.190.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sofwave Medical EV-to-FCF Related Terms
Sofwave Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sofwave Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sofwave Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sofwave Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sofwave Medical's EV-to-FCF falls into.
Sofwave Medical's current Enterprise Value is $458.40 Mil.
Sofwave Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sofwave Medical (SOFWF) has a EV-to-FCF of 34.76 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sofwave Medical and its competitors. According to the industry distribution chart, Sofwave Medical ranks #277 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 66.3%.
Is Sofwave Medical's EV-to-FCF too high?
Sofwave Medical's current EV-to-FCF is 34.76. The Medical Devices & Instruments industry median EV-to-FCF is 22.77. Sofwave Medical's value of 34.76 is 52.7% above this industry median. Based on the distribution chart, Sofwave Medical ranks #277 out of 418 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #277 out of 418 companies for EV-to-FCF. This places Sofwave Medical in the lower half of its industry. The industry median EV-to-FCF is 22.77. Sofwave Medical's value of 34.76 is 52.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.77, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current EV-to-FCF of 34.76 is 52.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current EV-to-FCF is 34.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.23, compared to a current price of $16.00 — trading 42.5% above its estimated fair value. The current EV-to-FCF is 34.76 and 52.7% above the Medical Devices & Instruments industry median of 22.77. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current EV-to-FCF is 34.76 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sofwave Medical (SOFWF) Overvalued in 2026?
Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued.
The current stock price of $16.00 is trading 42.5% above its estimated GF Value™ of $11.23.
GuruFocus considers Sofwave Medical to be Significantly Overvalued.
Key valuation signals for SOFWF:
EV-to-FCF: 34.76
GF Value™: $11.23 vs. price of $16.00 (42.5% above fair value)
Industry Position: 52.7% above the Medical Devices & Instruments median (#277 of 418)
No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOFWF has been successfully added to your 
